Prestige Consumer Healthcare Inc.
NYSE:PBHMedical - Distribution
+$0.23 today
- Market cap
- $2.40B
- Beta
- 0.35
- P/E (TTM)
- 11.6
- EPS (TTM)
- $4.01
Volume 0.62M
Average 0.67M
PBH Operating Cash Flow
Cash generated by the company's core business operations during the period.
Prestige Consumer Healthcare Inc.NYSE: PBH
Operating Cash Flow · Q1 FY2027 · quarter ended Jun 2026
Operating cash flow declines year over year
Q1 FY2027 operating cash flow of $70.79M fell 10.4% year over year, behind the -9.6% change in trailing-twelve-month operating cash flow. Sequentially, it rose 65.2% from the prior quarter. Over 3 fiscal years it compounded at +3.9% a year.
Context
- Operating cash flow amounted to 23.7% of revenue in FY2026, up 1.6 pp from a year earlier.
- Operating cash flow increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -10.4% toward the trailing-twelve-month pace of -9.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2026
- 257.63M USD
- Year-over-year change
- +2.4%
- 4-year CAGR
- -0.2%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 257.63M | +2.4% |
| FY2025 | 2025-03-31 | 251.52M | +1.0% |
| FY2024 | 2024-03-31 | 248.93M | +8.4% |
| FY2023 | 2023-03-31 | 229.72M | -11.6% |
| FY2022 | 2022-03-31 | 259.92M | — |
Operating Cash Flow vs competitors
How PBH compares with its peers on the latest reported figures
- PBH's LTM Jun 2026 operating cash flow of $249.4M is the 2nd largest of the 11 companies compared; the peer median is $91.35M.
- Its year-over-year change of -9.6% is the 8th highest of 11, against a peer median of +21.9%.
- Operating cash flow amounts to 22.6% of revenue for PBH, versus a peer median of 15.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $326.79M | +28.4% | +0.6% | 14.0% |
| LTM Jun 2026 | $249.4M | -9.6% | +3.9% | 22.6% | |
| LTM Sep 2026 | $247.8M | +45.7% | -20.7% | 18.2% | |
| LTM Sep 2026 | $237.8M | -5.1% | +53.8% | 15.8% | |
| LTM Jun 2026 | $236.37M | +70.3% | — | 10.9% | |
| LTM Mar 2026 | $208.21M | -22.3% | +21.6% | 34.9% | |
IRONDisc Medicine, Inc. | LTM Sep 2026 | $189.94M | +15.3% | +62.2% | — |
| LTM Jun 2026 | $133.38M | -23.9% | -25.7% | 29.7% | |
| LTM Jun 2026 | $131.13M | +42.7% | +51.3% | 5.6% | |
| LTM Mar 2026 | $51.56M | +558.2% | — | 6.6% | |
HTFLHeartflow, Inc. Common Stock | LTM Sep 2026 | $48.95M | -14.8% | — | 20.5% |
| Peer median (excluding PBH) | $91.35M | +21.9% | +21.6% | 15.8% | |
Competitors are the stored peer set for PBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | 205.38M | (82.31M) | 209.34M | 214.61M | 190.3M |
| Depreciation & Amortization | 32.09M | 32.63M | 30.68M | 30.17M | 31.27M |
| Deferred Income Tax | 9.98M | (60.77M) | 23.07M | 14.41M | 22.7M |
| Stock-Based Compensation | 9.04M | 12.41M | 14.01M | 11.16M | 10.84M |
| Change in Working Capital | (10.95M) | (53.86M) | (39.83M) | (41.94M) | (17.62M) |
| Accounts Receivables | (24.65M) | (24.93M) | (6.32M) | (16.33M) | (3.69M) |
| Inventory | 663K | (42.23M) | 24.44M | (9.31M) | (1.6M) |
| Accounts Payables | 9.15M | 7.26M | (24.97M) | (19.41M) | (151K) |
| Other Working Capital | 3.89M | 6.04M | (32.98M) | 3.11M | (12.19M) |
| Other Non-Cash Items | 14.38M | 381.61M | 11.66M | 23.11M | 20.14M |
| Operating Cash Flow | 259.92M | 229.72M | 248.93M | 251.52M | 257.63M |
| Capital Expenditures | (9.64M) | (7.78M) | (9.55M) | (8.22M) | (11.18M) |
| Acquisitions (Net) | (246.87M) | (3.8M) | (10.56M) | (9.23M) | (123.74M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (1.93M) |
| Investing Cash Flow | (256.51M) | (11.58M) | (20.11M) | (17.45M) | (136.84M) |
| Debt Repayment | (5.58M) | (137.75M) | (227.83M) | (139.54M) | 504K |
| Common Stock Issued | 7.04M | 0 | 0 | 14.8M | 4.29M |
| Common Stock Repurchased | 0 | (50M) | (25M) | (51.51M) | (156.28M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (9.03M) | 1.91M | 11.81M | (5.83M) | (4.57M) |
| Financing Cash Flow | (7.57M) | (185.85M) | (241.02M) | (182.08M) | (156.06M) |
| Effect of Forex Changes | (959K) | (982K) | 180K | (573K) | 1.26M |
| Net Change in Cash | (5.12M) | 31.3M | (12.02M) | 51.42M | (34.02M) |
| Free Cash Flow | 250.28M | 221.93M | 239.38M | 243.29M | 246.45M |
Prestige Consumer Healthcare Inc.
NYSE:PBH
Intrinsic Alpha fair value
Locked
Current Price
$50.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.